MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

Phase 1

Completed

Conditions: Cardiorenal Syndrome (CRS)

Interventions: Drug: Placebo
Drug: Candesartan

First Posted Date: 2012-09-05

Last Posted Date: 2021-11-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 33

Registration Number: NCT01678794

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

SCD Use to Prevent Deep Venous Thrombosis (DVT) in Patients With PICC Lines

Not Applicable

Terminated

Conditions: Deep Vein Thrombosis

Interventions: Device: Pneumatic SCD - VenaFlow System (DJO Global)

First Posted Date: 2012-08-22

Last Posted Date: 2018-01-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 78

Registration Number: NCT01670188

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness

Phase 1

Completed

Conditions: Vestibular Migraine
Chronic Subjective Dizziness

Interventions: Drug: Sertraline
Drug: Verapamil

First Posted Date: 2012-08-21

Last Posted Date: 2015-08-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 32

Registration Number: NCT01669304

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Pasireotide LAR in Severe Polycystic Liver Disease

Phase 2

Completed

Conditions: Somatostatin Analogs
Polycystic Liver Disease
Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Liver Disease

Interventions: Drug: Pasireotide LAR
Drug: Placebo

First Posted Date: 2012-08-21

Last Posted Date: 2020-05-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 48

Registration Number: NCT01670110

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Phase 2

Withdrawn

Conditions: Blastic Phase Chronic Myelogenous Leukemia
Untreated Adult Acute Lymphoblastic Leukemia
B-cell Adult Acute Lymphoblastic Leukemia
Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia
Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Interventions: Drug: nilotinib
Biological: rituximab
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: vincristine sulfate
Drug: methotrexate
Drug: cytarabine
Drug: prednisone
Drug: mesna
Drug: dexamethasone
Drug: leucovorin calcium

First Posted Date: 2012-08-21

Last Posted Date: 2015-10-30

Lead Sponsor: Mayo Clinic

Registration Number: NCT01670084

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough

Completed

Conditions: Scleroderma Lung

First Posted Date: 2012-08-17

Last Posted Date: 2016-01-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 7

Registration Number: NCT01667042

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth

Phase 3

Completed

Conditions: Parkinson's Disease

Interventions: Drug: Rifaximin

First Posted Date: 2012-08-10

Last Posted Date: 2016-08-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 49

Registration Number: NCT01662791

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study

Completed

Conditions: End Stage Liver Disease

Interventions: Other: cardiopulmonary exercise testing

First Posted Date: 2012-08-07

Last Posted Date: 2013-12-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 6

Registration Number: NCT01658982

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Diagnostic Test: Molecular breast imaging

First Posted Date: 2012-07-31

Last Posted Date: 2017-09-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 83

Registration Number: NCT01653964

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Endoscopic Full Thickness Biopsy, Gastric Wall.

Not Applicable

Completed

Conditions: Gastroparesis

Interventions: Procedure: Full thickness gastric biopsy

First Posted Date: 2012-07-26

Last Posted Date: 2015-05-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 3

Registration Number: NCT01650714

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy